12:00 AM
 | 
Oct 29, 2012
 |  BC Week In Review  |  Company News  |  Deals

Prometic, Shenzhen Hepalink Pharmaceutical deal

The companies partnered to research and develop ProMetic's protein technologies. ProMetic will receive $2 million up front, and is eligible to receive up to $9 million in licensing fees and milestone payments. Shenzhen Hepalink...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >